These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
209 related articles for article (PubMed ID: 32184287)
1. PTPN22 phosphorylation acts as a molecular rheostat for the inhibition of TCR signaling. Yang S; Svensson MND; Harder NHO; Hsieh WC; Santelli E; Kiosses WB; Moresco JJ; Yates JR; King CC; Liu L; Stanford SM; Bottini N Sci Signal; 2020 Mar; 13(623):. PubMed ID: 32184287 [TBL] [Abstract][Full Text] [Related]
2. A novel gain-of-function phosphorylation site modulates PTPN22 inhibition of TCR signaling. Zhuang C; Yang S; Gonzalez CG; Ainsworth RI; Li S; Kobayashi MT; Wierzbicki I; Rossitto LM; Wen Y; Peti W; Stanford SM; Gonzalez DJ; Murali R; Santelli E; Bottini N J Biol Chem; 2024 Jun; 300(6):107393. PubMed ID: 38777143 [TBL] [Abstract][Full Text] [Related]
3. TRAF3 enhances TCR signaling by regulating the inhibitors Csk and PTPN22. Wallis AM; Wallace EC; Hostager BS; Yi Z; Houtman JCD; Bishop GA Sci Rep; 2017 May; 7(1):2081. PubMed ID: 28522807 [TBL] [Abstract][Full Text] [Related]
4. PTPN22 interacts with EB1 to regulate T-cell receptor signaling. Zhang X; Yu Y; Bai B; Wang T; Zhao J; Zhang N; Zhao Y; Wang X; Wang B FASEB J; 2020 Jul; 34(7):8959-8974. PubMed ID: 32469452 [TBL] [Abstract][Full Text] [Related]
5. Autoimmune-associated PTPN22 R620W variation reduces phosphorylation of lymphoid phosphatase on an inhibitory tyrosine residue. Fiorillo E; Orrú V; Stanford SM; Liu Y; Salek M; Rapini N; Schenone AD; Saccucci P; Delogu LG; Angelini F; Manca Bitti ML; Schmedt C; Chan AC; Acuto O; Bottini N J Biol Chem; 2010 Aug; 285(34):26506-18. PubMed ID: 20538612 [TBL] [Abstract][Full Text] [Related]
6. Crispr/Cas Mediated Deletion of PTPN22 in Jurkat T Cells Enhances TCR Signaling and Production of IL-2. Bray C; Wright D; Haupt S; Thomas S; Stauss H; Zamoyska R Front Immunol; 2018; 9():2595. PubMed ID: 30483260 [TBL] [Abstract][Full Text] [Related]
8. Identification of substrates of human protein-tyrosine phosphatase PTPN22. Wu J; Katrekar A; Honigberg LA; Smith AM; Conn MT; Tang J; Jeffery D; Mortara K; Sampang J; Williams SR; Buggy J; Clark JM J Biol Chem; 2006 Apr; 281(16):11002-10. PubMed ID: 16461343 [TBL] [Abstract][Full Text] [Related]
9. Use of short interfering RNA delivered by cationic liposomes to enable efficient down-regulation of PTPN22 gene in human T lymphocytes. Perri V; Pellegrino M; Ceccacci F; Scipioni A; Petrini S; Gianchecchi E; Lo Russo A; De Santis S; Mancini G; Fierabracci A PLoS One; 2017; 12(4):e0175784. PubMed ID: 28437437 [TBL] [Abstract][Full Text] [Related]
10. The autoimmunity risk variant LYP-W620 cooperates with CSK in the regulation of TCR signaling. de la Puerta ML; Trinidad AG; Rodríguez Mdel C; de Pereda JM; Sánchez Crespo M; Bayón Y; Alonso A PLoS One; 2013; 8(1):e54569. PubMed ID: 23359562 [TBL] [Abstract][Full Text] [Related]
12. Multifunctional roles of the autoimmune disease-associated tyrosine phosphatase PTPN22 in regulating T cell homeostasis. Salmond RJ; Brownlie RJ; Zamoyska R Cell Cycle; 2015; 14(5):705-11. PubMed ID: 25715232 [TBL] [Abstract][Full Text] [Related]
13. LYP inhibits T-cell activation when dissociated from CSK. Vang T; Liu WH; Delacroix L; Wu S; Vasile S; Dahl R; Yang L; Musumeci L; Francis D; Landskron J; Tasken K; Tremblay ML; Lie BA; Page R; Mustelin T; Rahmouni S; Rickert RC; Tautz L Nat Chem Biol; 2012 Mar; 8(5):437-46. PubMed ID: 22426112 [TBL] [Abstract][Full Text] [Related]
14. Overexpression of the Perry DJ; Peters LD; Lakshmi PS; Zhang L; Han Z; Wasserfall CH; Mathews CE; Atkinson MA; Brusko TM J Immunol; 2021 Aug; 207(3):849-859. PubMed ID: 34301848 [TBL] [Abstract][Full Text] [Related]
15. Increased expression of protein tyrosine phosphatase nonreceptor type 22 alters early T-cell receptor signaling and differentiation of CD4 Liu M; Xia N; Zha L; Yang H; Gu M; Hao Z; Zhu X; Li N; He J; Tang T; Nie S; Zhang M; Lv B; Lu Y; Jiao J; Li J; Cheng X FASEB J; 2024 Jan; 38(1):e23386. PubMed ID: 38112398 [TBL] [Abstract][Full Text] [Related]
16. The Csk-Associated Adaptor PAG Inhibits Effector T Cell Activation in Cooperation with Phosphatase PTPN22 and Dok Adaptors. Davidson D; Zhong MC; Pandolfi PP; Bolland S; Xavier RJ; Seed B; Li X; Gu H; Veillette A Cell Rep; 2016 Dec; 17(10):2776-2788. PubMed ID: 27926878 [TBL] [Abstract][Full Text] [Related]
17. Protein tyrosine phosphatase PTPN22 regulates IL-1β dependent Th17 responses by modulating dectin-1 signaling in mice. Purvis HA; Clarke F; Jordan CK; Blanco CS; Cornish GH; Dai X; Rawlings DJ; Zamoyska R; Cope AP Eur J Immunol; 2018 Feb; 48(2):306-315. PubMed ID: 28948613 [TBL] [Abstract][Full Text] [Related]
18. Structure, inhibitor, and regulatory mechanism of Lyp, a lymphoid-specific tyrosine phosphatase implicated in autoimmune diseases. Yu X; Sun JP; He Y; Guo X; Liu S; Zhou B; Hudmon A; Zhang ZY Proc Natl Acad Sci U S A; 2007 Dec; 104(50):19767-72. PubMed ID: 18056643 [TBL] [Abstract][Full Text] [Related]
19. Leukocyte-associated immunoglobulin-like receptor 1 inhibits T-cell signaling by decreasing protein phosphorylation in the T-cell signaling pathway. Park JE; Brand DD; Rosloniec EF; Yi AK; Stuart JM; Kang AH; Myers LK J Biol Chem; 2020 Feb; 295(8):2239-2247. PubMed ID: 31932281 [TBL] [Abstract][Full Text] [Related]
20. A switch-variant model integrates the functions of an autoimmune variant of the phosphatase PTPN22. Vang T; Nielsen J; Burn GL Sci Signal; 2018 Apr; 11(526):. PubMed ID: 29666305 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]